Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (-)-Guaiol Against Lung Adenocarcinoma

Yaoying Zeng; Yanbin Pan; Bo Zhang; Yingbin Luo; Jianhui Tian; Yuli Wang; Xudong Ju; Jianchun Wu; Yan Li

doi:10.12659/MSM.937131

25 July 2022 : Database Analysis

Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (-)-Guaiol Against Lung Adenocarcinoma

Yaoying Zeng^1E, Yanbin Pan^1B, Bo Zhang^1C, Yingbin Luo^1D, Jianhui Tian^1AF, Yuli Wang^1CD, Xudong Ju^2BF, Jianchun Wu^1A*, Yan Li^1A

DOI: 10.12659/MSM.937131

Med Sci Monit 2022; 28:e937131

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 6 KEGG pathway-target network. The orange round nodes represent the top 19 related targets and the green round nodes represent the top 20 pathways.

Back to the Article

Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (-)-Guaiol Against Lung Adenocarcinoma

Your Privacy